Clinical trial
Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year…
NCT00368316 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00368316 |
|---|---|
| Title | Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel |
| Official title | Phase 3 Study (Safety, Immunogenicity and Efficacy) of Improved Shigella Conjugate Vaccines in 1-4 Year Olds in Israel |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Collaborators | The Chaim Sheba Medical Center Schneider Children's Medical Center, Israel |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Shigellosis |
| Intervention type | Biological |
| Interventions | Shigella conjugate vaccines |
| Enrollment | 2,799 |
| Start date | Jan 1, 2003 |
| Primary completion | Jan 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | Aug 24, 2006 |
| Last update posted | Jun 22, 2012 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: